Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients.
作者信息
Takazono Takahiro, Ngwe Tun Mya Myat, Funakoshi Satoshi, Morimoto Shimpei, Ota Kenji, Torigoe Kenta, Abe Shinichi, Muta Kumiko, Ito Yuya, Ashizawa Nobuyuki, Kitamura Mineaki, Takeda Kazuaki, Iwanaga Naoki, Ide Shotaro, Tashiro Masato, Hosogaya Naoki, Nishino Tomoya, Yanagihara Katsunori, Izumikawa Koichi, Morita Kouichi, Mukae Hiroshi
机构信息
Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
出版信息
Kidney Int Rep. 2023 Jun 17;8(9):1883-1886. doi: 10.1016/j.ekir.2023.06.008. eCollection 2023 Sep.
Abstract
摘要
相似文献
1
Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis Patients.
Kidney Int Rep. 2023 Jun 17;8(9):1883-1886. doi: 10.1016/j.ekir.2023.06.008. eCollection 2023 Sep.
2
Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2105611. doi: 10.1080/21645515.2022.2105611. Epub 2022 Sep 12.
3
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.
Microbiol Spectr. 2022 Oct 26;10(5):e0131522. doi: 10.1128/spectrum.01315-22. Epub 2022 Sep 19.
4
In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant.
Transbound Emerg Dis. 2022 Sep;69(5):2649-2655. doi: 10.1111/tbed.14417. Epub 2022 Jan 3.
5
Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients.
Int Urol Nephrol. 2022 Aug;54(8):1939-1945. doi: 10.1007/s11255-021-03076-2. Epub 2021 Dec 3.
6
BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents.
Front Immunol. 2021 Sep 29;12:743422. doi: 10.3389/fimmu.2021.743422. eCollection 2021.
7
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.
Vaccines (Basel). 2022 Feb 18;10(2):327. doi: 10.3390/vaccines10020327.
8
Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.
Clin Exp Nephrol. 2022 Sep;26(9):925-932. doi: 10.1007/s10157-022-02223-y. Epub 2022 Apr 15.
9
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.
Front Immunol. 2022 Mar 4;13:840136. doi: 10.3389/fimmu.2022.840136. eCollection 2022.
10
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Front Immunol. 2021 Jun 16;12:704773. doi: 10.3389/fimmu.2021.704773. eCollection 2021.
引用本文的文献
1
Serological Correlate of Protection Established by Neutralizing Antibodies Differs Among Dialysis Patients with SARS-CoV-2 Variants of Concern.
Vaccines (Basel). 2025 May 13;13(5):518. doi: 10.3390/vaccines13050518.
2
SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine.
Vaccines (Basel). 2024 Mar 15;12(3):308. doi: 10.3390/vaccines12030308.
本文引用的文献
1
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients.
Kidney Int Rep. 2022 Dec;7(12):2718-2721. doi: 10.1016/j.ekir.2022.09.005. Epub 2022 Sep 11.
2
Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis.
Sci Prog. 2022 Jul-Sep;105(3):368504221110858. doi: 10.1177/00368504221110858.
3
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis.
Immunol Res. 2022 Aug;70(4):493-500. doi: 10.1007/s12026-022-09283-y. Epub 2022 May 11.
4
Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.
Nephrol Dial Transplant. 2022 May 25;37(6):1132-1139. doi: 10.1093/ndt/gfac018.
5
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis.
Autoimmun Rev. 2022 Jan;21(1):102927. doi: 10.1016/j.autrev.2021.102927. Epub 2021 Aug 30.
6
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1037-1042. doi: 10.2215/CJN.03500321. Epub 2021 Apr 6.
7
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
8
High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan.
Ther Apher Dial. 2012 Jun;16(3):226-31. doi: 10.1111/j.1744-9987.2012.01062.x. Epub 2012 Apr 2.
9
Effect of uremia on structure and function of immune system.
J Ren Nutr. 2012 Jan;22(1):149-56. doi: 10.1053/j.jrn.2011.10.020.
Zotero 插件